Agilon 医疗 AGL

Jeffrey Schwaneke has served as the Company's Chief Financial Officer since July 2024 and co-Interim Principal Executive Officer since July 2025. Previously, Mr. Schwaneke served as a member of the Board of Directors from 2022 to 2024. Mr. Schwaneke served as the Executive Vice President of Health Care Enterprises for Centene Corporation, a managed health care company, from June to September 2021, and as Executive Vice President, Chief Financial Officer and Treasurer from March 2016 to May 2021. Mr. Schwaneke joined Centene Corporation in July 2008 as Senior Vice President, Corporate Controller and Chief Accounting Officer. Prior to joining Centene Corporation, Mr. Schwaneke served as the Assistant Controller and then as Chief Accounting Officer of Novelis, Inc., a rolled aluminum manufacturing company, from 2006 through 2008.Mr. Schwaneke received a B.S. in Accounting from the University of Missouri and is a CPA.

Benjamin Shaker has served as the Company's Chief Markets Officer since September 2020 and co-Interim Principal Executive Officer since July 2025. Mr. Shaker joined agilon as Ohio Market President in January 2017. Previously, Mr. Shaker served as Vice President and Chief Operating Officer for Mount Carmel Health Partners, which is part of Trinity Health, a non-profit health system, from December 2013 to January 2017. Mr. Shaker received his B.A. from Youngstown State University and master's degree in Health Administration from The Ohio State University.

Denise Zamore has served as the Company's Chief Legal Officer and Corporate Secretary since August 2022. She has also served as the interim Chief People Officer since October 2025. Prior to agilon, Ms. Zamore held several positions with UnitedHealth Group, Inc., a health insurance and healthcare services company, from April 2011 to August 2022. Most recently, Ms. Zamore served as Deputy General Counsel at Optum, Inc., a health services and innovation company and subsidiary of UnitedHealth Group, Inc., where she led a team providing operational and strategic support to physician groups and health care executives on matters including mergers and acquisitions, regulatory guidance, state regulation of risk-bearing entities, and compliance. Ms. Zamore also led the coordination and management of nationwide legal, regulatory, and compliance matters related to all lines of health insurance business during her time with UnitedHealth Group, Inc. Earlier in her career, Ms. Zamore worked at several large national law firms and completed a federal clerkship. Ms. Zamore received her B.A. in Government from Georgetown University and her J.D. from Columbia Law School.

Karen McLoughlin has served as a director since 2021. Ms. McLoughlin has served as a Senior Advisor to McKinsey & Company, a global management consulting firm, since 2022. Previously, Ms. McLoughlin served as Chief Financial Officer of Cognizant Technology Solutions Corporation, a leading provider of information technology, business process and consulting services, from 2012 to 2020. Prior to joining Cognizant Technology Solutions Corporation in 2003, Ms. McLoughlin served in financial roles for Spherion Corp. (now SFN Group Inc.), a provider of temporary and permanent staffing solutions to businesses, from 1997 to 2003; Ryder System, Inc. from 1994 to 1997; and Price Waterhouse (now PricewaterhouseCoopers), an accounting firm, from 1988 to 1994. Ms. McLoughlin currently serves as a director of Best Buy Co., Inc. where she is a member of the Audit Committee and Chair of the Finance and Investment policy committee. She also previously served as a director and chair of the Audit Committee of Nexthink from August 2024 to March 2026 . Ms. McLoughlin received her B.A. from Wellesley College and her M.B.A. from Columbia University.

Diana McKenzie has served as a director since 2023. Ms. McKenzie is the owner of and a consultant with DLM Horizons LLC. She has served as a Senior Advisor to Brighton Park Capital, an investment firm specializing in software, information services, technology-enabled business services and healthcare, since 2019 and as a Special Advisor to Red Cell Partners LLC, a venture capital firm, since 2024. Ms. McKenzie previously served as the first Chief Information Officer of Workday, Inc., a provider of enterprise cloud applications, from 2016 to 2019. Prior to that, she held multiple technology leadership roles at Amgen, Inc., a biopharmaceutical company, from 2004 to 2016, including Chief Information Officer, and served in various technology positions at Eli Lilly and Company, a pharmaceutical company, from 1987 to 2004. Ms. McKenzie currently serves as a director of MetLife, Inc., where she is a member of the Audit, Compensation, and Finance and Risk Committees. She is also a director of Vertex Pharmaceuticals Incorporated, where she serves on the Audit and Management Development and Compensation Committees. Ms. McKenzie previously served on the board of Change Healthcare Inc. from 2019 to 2022 and Paradox, Inc. from 2020 to 2025. She received her B.S. from Purdue University.

Sharad Mansukani, M.D. has served as a director since 2017. Dr. Mansukani has served as a Senior Advisor to TPG, a private equity firm, since 2005. He currently serves as a director of Monogram Health, Inc. and as Chairman of the board of directors of Convey Health Solutions. He also serves as a member of The Wharton School Healthcare Policy Board and as a trustee of the Children's Hospital of Philadelphia. Dr. Mansukani previously served as Chairman of the board of directors of Envision Rx Options from 2013 to 2016; as a strategic advisor to the board of directors of Cigna Corp. from 2012 to 2015; as Vice Chairman of the board of directors of HealthSpring, Inc. from 2007 to 2012; as a director of IMS Health Holdings, Inc. from 2009 to 2016; as a director of Surgical Care Affiliates, Inc. from 2007 to 2017; as Lead Director of IASIS Healthcare from 2005 to 2018; and as a director of Kindred Healthcare, Inc. from 2015 to 2018. Dr. Mansukani has also served as a Senior Advisor on Medicare's Program Advisory and Oversight Committee to the Secretary of the U.S. Department of Health and Human Services; as Senior Advisor to the Administrator of the Centers for Medicare & Medicaid Services; and as Senior Vice President and Chief Medical Officer of Health Partners. Dr. Mansukani completed a residency and fellowship in ophthalmology at the University of Pennsylvania School of Medicine and a fellowship in quality management and managed care at The Wharton School of the University of Pennsylvania. He is a graduate of the Managed Care Executive Program at the Kellogg School of Management.

Silvana Battaglia has served as a director since 2023. Ms. Battaglia is Executive Vice President and Chief Human Resources Officer for Cencora, Inc. (formerly AmerisourceBergen), a leading global healthcare solutions company. She has served as an Executive Advisor to SemperVirens Venture Capital since September 2025. Prior to her current role, Ms. Battaglia served as Senior Vice President of Global Compensation, Benefits and Labor Relations and Senior Vice President of Global Human Resources at Aramark, Inc., a provider of managed services to business, educational, healthcare, governmental and other institutions, from 2011 to 2019. Ms. Battaglia served as the Chief Human Resources Officer of Day & Zimmermann, Inc., a global manufacturing company, from 2008 to 2011 and held leadership positions with Merck & Co., Inc., a global biopharmaceutical company, from 1998 to 2008. Earlier in her career, she held positions at Wyeth Pharmaceuticals, Inc. and Colorcon, a division of Berwind Pharmaceuticals. She has also served as an adjunct faculty member at St. Joseph's University in Philadelphia. Ms. Battaglia is a National Association of Corporate Directors certified professional director. She received her B.A. from Temple University and her M.S. from Widener University.

Ronald Williams is a co-founder of the Company and has served as a director and Chairman of the Board since 2017 and as Executive Chairman since 2025. Mr. Williams also serves as Chairman and Chief Executive Officer of RW2 Enterprises, through which he counsels C-Suite corporate executives, and serves as an operating advisor to CD&R, a private equity firm. Mr. Williams served as the Chief Executive Officer of Aetna Inc., a diversified healthcare benefits company, from 2006 to 2010, and as Chairman from 2006 to 2011. Mr. Williams currently serves as lead director of Warby Parker Inc., where he is the Chair of the Nominating and Corporate Governance Committee. He previously served as a director of The Boeing Company from 2010 to 2024, The American Express Company from 2007 to 2022, Johnson & Johnson from 2011 to 2022 and Envision Healthcare from 2011 to 2017. Mr. Williams also serves as Chairman of The Conference Board and as Trustee of the Peterson Institute for International Economics. He previously served as a director of NAF and on the boards of private companies apree health (previously Castlight / Vera Whole Health Inc.) and Millennium Physician Group. Mr. Williams received his B.A. from Roosevelt University and his M.S. from the MIT Sloan School of Management. Ronald A. Williams, who has served as Executive Chairman since August 2025 and will continue as Chairman of the Board effective 7th May 2026.

On April 24, 2026, agilon health, inc. entered into an Employment Agreement with Mr. Tim O'Rourke, pursuant to which Mr. O'Rourke will serve as the Company's Chief Executive Officer and President, reporting to the Board of Directors. Mr. O'Rourke is expected to commence employment with the Company on May 7, 2026. Effective as of the Commencement Date, the Board has also appointed Mr. O'Rourke to the Board as a Class III director. From May 2021 to June 2025, Mr. O'Rourke served as President of Help at Home, LLC, a home care agency providing alternatives to living in a nursing home or long-term care facility. Prior to his time at Help at Home, LLC, Mr. O'Rourke served as Managing Director of Marketplace for Centene Corporation from 2019 to 2020 and Chief Executive Officer of Ascension Complete LLC, a joint venture between Centene Corporation and Ascension Health, from November 2020 to May 2021. From 1996 to 2019, Mr. O'Rourke held several positions at Humana, Inc., including Senior Vice President of the Central Division and President of Provider Development. Mr. O'Rourke received a B.S. in Public Health, Health Administration from Northern Illinois University.

Ravi Sachdev has served as a director since 2017 and as Vice Chairman since 2021. Mr. Sachdev has also served as a Partner of CD&R since 2015, focusing on the healthcare sector. Mr. Sachdev currently serves as a director of Steve Madden, Inc., where he is a member of the Audit Committee and the Nominating/Corporate Governance Committee, and as a director of Millennium Physician Group, apree health (previously Castlight / Vera Whole Health, Inc.), and Gentiva Health Services. From 2010 to 2015, Mr. Sachdev served as a Managing Director and Co-Head of Healthcare Services at J.P. Morgan Chase & Co., a global financial services firm. From 2009 to 2010, he served as a Managing Director at Deutsche Bank Securities, Inc., a subsidiary of Deutsche Bank AG, a global investment bank and financial services firm. From 1998 to 2006, he served as a Vice President at Peter J. Solomon Company, an investment banking boutique specializing in mergers and acquisitions in the healthcare sector. Mr. Sachdev received his B.A. from the University of Michigan.

On August 11, 2023, Timothy Gertsch, agilon heath's Vice President, Controller was appointed as Chief Accounting Officer on August 16, 2023. Mr. Gertsch, age 37, has served as Vice President, Controller at agilon health since April 2022. Prior to his current role, Mr. Gertsch served in a number of senior accounting positions at agilon health, including serving as Accounting Director upon joining agilon health in 2020 and as acting Chief Accounting Officer from May 2022 to September 2022. Prior to joining agilon health, Mr. Gertsch served as a Senior Manager at The Siegfried Group from 2018 to 2020, where he supported agilon health's accounting functions. Prior to his role at The Siegfried Group, Mr. Gertsch served as a Manager at Protiviti from 2016 to 2018. Mr. Gertsch received a Bachelor of Science and a Master of Accounting from the University of Utah and is a Certified Public Accountant.